20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates | news.google.com • |
Fed Day: 5 Things Investors Need to Know for FOMC Meeting | zacks.com • |
SPY: Equity And Bond Markets Flash Conflicting Signals On Recession Risk | seekingalpha.com • |
SPY: 3 Paths for Stocks AFTER Fed Meeting | news.google.com • |
From Silicon Valley to ETFs: TappAlpha CEO Katara Talks Options Income ETF TSPY | etftrends.com • |
New Gamma ETF Mixes Large-Cap & T-Bill Exposure | etftrends.com • |
Dividend | Date |
---|---|
1.75902 | 2024-06-21 |
1.59494 | 2024-03-15 |
1.90607 | 2023-12-15 |
1.58317 | 2023-09-15 |
1.63837 | 2023-06-16 |
1.5062 | 2023-03-17 |
-
When the SPY finally does a HTZ it gonna feel SOOOOOO GOOD
-
Just an extra little PAMP! Lol.
-
What Fed is doing to the markets is outward criminal. The US dollar is worth may be at best 5-10 cents. Inflation is the most important factor in the economy. Inflation is a hidden taxation. I don’t know why would anyone be happy right now. Children in America are born with at least 100K debt.
-
FAUCI IS A FRAUD
-
If we had an African Mooslem Puppet President we could make China happy
Or maybe just sleepy Joe -
$SAVA - A second opinion
*
If you have been following Cassava and their Alzheimers drug PTI-125, you will know that 1 of 2 trial endpoints was not recently met, sending the stock down almost 80%. But, I think the exodus was premature. Here is why:Per the companys press release, one endpoint WAS MET:
A secondary endpoint of CSF levels of IL1-beta, a core biomarker of neuroinflammation from baseline to day 28, was met, Cassava said. The drug was also found to be safe and well-tolerated.Per NIH, neuro inflammation is the CORE issue with Alzheimers:
Inflammation in Alzheimer's disease (AD) has emerged as a central pathology that likely plays a role in onset and progression of the disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214864/Cycling back to Cassavas press release, they state:
CSF levels of IL1-beta, a core biomarker of neuroinflammation ... was met
To reiterate the NIH definition, Neuro Inflammation is core to the onset and progression of Alzheimers. At some point, Cassava IS going to cycle back around to the secondary endpoint (neuro inflammation), and realize that ALONE constitutes an ALZHEIMER DRUG THAT WORKS.
In this case, traders were SO tuned into the word miss that they MISSED something EXTREMELY IMPORTANT -> The efficacy of PTI-125 towards Neuro Inflammation, in Alzheimers (ALONE), makes it A BLOCKBUSTER DRUG!
-
-
Sleepy Joe is the perfect puppet to make China happy
-
Maybe if we get another African Mooslem puppet President, everything will be ok
At least we can make China happy -
The Jew Jim Cramer, pumping China on CNBC.
He Lives China and Pelosi -
Did someone just say New York Lotto is offering Mega Millions? Or maybe I might’ve heard Wall street is offering Mega Millions?
-
-
-
-
-
-
-
SPY: Equity And Bond Markets Flash Conflicting Signals On Recession Risk
seekingalpha.com • -
SPY: 3 Paths for Stocks AFTER Fed Meeting
news.google.com • -
New Gamma ETF Mixes Large-Cap & T-Bill Exposure
etftrends.com • -
Market Internals Signal Upside Breakout
forbes.com • -
SPY ETF Update, 9/17/2024
news.google.com • -
5 Stocks That Led the SPY ETF to Log Its Best Week in 2024
news.google.com • -
(SPY) Pivots Trading Plans and Risk Controls
news.google.com •